Diabetes Publications

Posters, Publications & Research

Warholak T, Leal S, Lee A, Patel, N. A Consumer Assessment of Pharmaceutical Care Services in a Diabetes Ambulatory Clinic. AzPA Health-System Heartbeat, Spring 2011: pp 4-6. http://www.azpharmacy.org/associations/10285/files/HSA_Newsletter_Spring_2011.pdf

Endsley S, Leal S, Choi J, Martinez AN. An Office Based Physician Education Program to Enhance the Earlier Initiation of Insulin: An Evaluation of an Academic Detailing Intervention in the US. Accepted for oral presentation at the American Diabetes Association's 70th Scientific Sessions, Orlando, FL, June, 2010. Pending publication in the Scientific Sessions Abstract Book June 2010 supplement to the journal Diabetes.

Rust G, Leal S. Cost-Effective Prescribing vs. Moments of Compromise: An educational tool designed for prescribers in the Community and Migrant Health Center environment free of pharmaceutical influence. National Center for Farmworker Health, Inc. (NCFH). CD-ROM. 2009.

Leal S, Soto-Rowen M. Usefulness of Point-of-Care Testing in the Treatment of Diabetes in an Underserved Population. Journal of Diabetes Science and Technology 2009;3(4):672-676.

Leal S. Cost Effective Prescribing versus Moments of Compromise. Migrant Health Newsline Vol. 26, No. 2. March/April 2009.

Dingham J, Glenn ZM, Leal S. Improving Patient Safety-Improving Lives: A Patient’s Story. Journal of Health Care for the Poor and Underserved 20(1):1-3, February 2009.

Patel N, Lee AA, Warholak T, Leal S. A Consumer Assessment of Pharmaceutical Care Services in a Diabetes Ambulatory Clinic. Poster presentation at the 43rd American Society of Health-Systems Pharmacist (ASHP) Midyear Clinical Meeting and Exhibition, Orlando, FL, December 2008.

Leal S. Long-Acting Insulins for the Treatment of Type 2 Diabetes. Pharmacy Times, October 2008: pp 38-40. http://www.pharmacytimes.com/issues/articles/2008-10_005.asp

Leal S. Increasing Patient Access and Improving Patient Outcomes in Diabetes through Pharmacy-Based Disease Management Services. Poster presentation at the Community Health Institute (CHI) & EXPO for the National Association of Community Health Centers (NACHC), New Orleans, LA, September 2008.

Leal S, Leal K. Back to basics: helping patients pick ‘real’ food. 2008 Diabetes Educators’ Handbook, A Supplement to Endocrine today, Vol 6, No 14 (August 10), 2008: p 6.

Leal S, Soto ML. Chronic Kidney Disease Risk Reduction in a Hispanic Population Through Pharmacist-Based Disease-State Management. Advances in Chronic Kidney Disease, Vol 15, No 2 (April), 2008: pp 162-167.

Armin J, Shaw S, Schaecher A, Leal S, Petruski J. Nobody took time to tell me watch out for this: understanding risk and social support among people living with type 2 diabetes. Presentation for the Society for Applied Anthropology/Society for Medical Anthropology Meeting, Memphis, TN, March 2008.

Strickland C, Armstrong EP, Leal S. Pharmacist Knowledge of Inhaled Insulin. Poster presentation at the 42nd American Society of Health-Systems Pharmacist (ASHP) Midyear Clinical Meeting and Exhibition, Las Vegas, NV, December 2007.

Meneghini L, Kennedy L, Koff R, Kuritzky L, Leal S, Peterson K, Zamudio V. Appropriate Advancement of Type 2 Diabetes Therapy. Current Clinical Practice 1(1): 19a-30a, October 2007. http://www.jfponline.com/pdf/5610/5610ACCP_Supplement1.pdf

Leal S, Public Health Institute/Medpin’s Low Literacy Questions and Answers about Diabetes Treatment (English and Spanish), 2007.

Leal S, Herrier RN, Soto M. The Role of Rapid-Acting Insulin Analogues and Inhaled Insulin in Type 2 Diabetes Mellitus. Insulin 2(2):61-67, April 2007.

Hogan E, Leal S, Slack M, Apgar D. Pharmacist-Led vs Physician Diabetes Drug Management. Hospital Pharmacy Europe May/June 2006.

Leal S, Soto M, Felix A. Pharmacist-Based Diabetes Management through a Collaborative Practice Model. Poster presentation at the 40th American Society of Health-Systems Pharmacist (ASHP) Midyear Clinical Meeting and Exhibition, Las Vegas, NV, December 2005.

Hogan, EG, Leal S, Slack M, Apgar M. Comparison of pharmacist led collaborative drug therapy management to standard physician provided therapy for type 2 diabetes mellitus. Poster presentation at the 40th American Society of Health-Systems Pharmacist (ASHP) Midyear Clinical Meeting and Exhibition, Las Vegas, Nevada, December 2005.

Leal, S. Medications, Rationing, and Health Care: The Role of Pharmacists in Bridging the Gap. Journal of Health Care for the Poor and Underserved 16(3): 418-420, August 2005.

Leal, S. Changing the Face of Pharmacy. Rx for Access Volume 2 Issues 5 p.2, MedPin (Medicine for People in Need), July/August 2005.

Leal, S. Cambiando la Cara de la Farmacia. Rx for Access Volume 2 Issues 5 p.2, MedPin (Medicine for People in Need), Julio/Agosto 2005.

Burgos I, Westpheling K, Leal S, Levy R, Frazier E. Access to Medications by Underserved Populations: Recommendations for Process Improvement. Association of Clinicians for the Underserved (ACU), June 2005.

Leal S, Soto ML. Pharmacists Disease State Management Through a Collaborative Practice Model. Journal of Health Care for the Poor and Underserved 16(2):220-224, May 2005.

Leal S, Herrier RN, Glover JJ, Felix A. Improving Quality of Care in Diabetes Through a Comprehensive Pharmacist-Based Disease Management Program (Brief Report). Diabetes Care 27:2983–2984, 2004.

Understanding Medicare Reform. What Pharmacists Need to Know, Monograph 2: Medication Therapy Management Services and Chronic Care Improvement Programs. American Pharmacists Association (APhA) Resources, 2004.

Leal, S. Clinicians & Community: Primary Health Care, A Fellowship, and Change. Association of Clinicians for the Underserved (ACU), Summer 2004.

Goyette D, Disco ME, Leal S, Schwed DH. The pharmacist as a primary care provider for the medically underserved. Journal of the American Pharmacist Association (Wash DC). 2003 Sep-Oct;43(5 Suppl 1):S52-3.

Leal S, Ford M. A Retrospective Evaluation of the Clinical Use of Glycosylated Hemoglobin Levels in Diabetic Patients, Southern Arizona VA Health Care System. Tucson, AZ, 2000.

Brandt, T. L., Fraser, D. J., Leal, S., Halandras, P. M., Nelson, A. R., and Kroll, D. J. c-Myb trans-activates the human DNA topoisomerase II gene promoter. Journal of Biological Chemistry, 272:6278 –6284,1997.

c-Myb transactivates the human topoisomerase II-alpha gene promoter in HL-60 cells. Proc AM Assoc. Cancer Research. 36:451 (Abstract 2691).

Evaluation of HRSA's Clinical Pharmacy Demonstration Projects
Volume 1: Synthesis Report
Final evaluation report of the Clinical Pharmacy Demonstration Projects (CPDP) managed by OPA. The purpose of these projects was to examine the effects of expanded access to clinical pharmacists and comprehensive pharmacy services on the health outcomes of medically underserved populations. This report is an evaluation of expanded access and improved outcomes due to the Clinical Pharmacy Demonstration Projects.
ftp://ftp.hrsa.gov/bphc/pdf/opa/CPDPvolume1finalreport.pdf
November 30, 2004

Volume II: Case Studies
Presents five case studies of Clinical Pharmacy Demonstration Project networks whose experience may prove beneficial to other Community Health Centers and providers exploring the potential for clinical pharmacy service. El Rio’s Demonstration Project is highlighted.
ftp://ftp.hrsa.gov/bphc/pdf/opa/CPDPvolume2finalreport.pdf

November 30, 2004